4//SEC Filing
Van Naarden Jacob 4
Accession 0000059478-25-000057
CIK 0000059478other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:28 PM ET
Size
8.5 KB
Accession
0000059478-25-000057
Insider Transaction Report
Form 4
Van Naarden Jacob
EVP & Pres., Lilly Oncology
Transactions
- Award
Common Stock
2025-02-10$868.88/sh+6,103.824$5,303,491→ 19,561.985 total - Award
Restricted Stock Unit
2025-02-10+4,108→ 4,108 totalFrom: 2026-02-01Exp: 2026-02-01→ Common Stock (4,108 underlying)
Holdings
- 4,342(indirect: By Trust)
Common Stock
- 4,302(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Documents
Issuer
ELI LILLY & Co
CIK 0000059478
Entity typeother
Related Parties
1- filerCIK 0001661254
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:28 PM ET
- Size
- 8.5 KB